Bausch Health
BHC
232 hedge funds and large institutions have $2.13B invested in Bausch Health in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
3% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 38
1% less funds holding
Funds holding: 235 → 232 (-3)
3.8% less ownership
Funds ownership: 76.96% → 73.16% (-3.8%)
6% less capital invested
Capital invested by funds: $2.27B → $2.13B (-$145M)
14% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 69
61% less call options, than puts
Call options by funds: $67.8M | Put options by funds: $174M
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$44.2M |
| 2 |
GAM
Goldentree Asset Management
New York
|
+$26M |
| 3 |
GCM
Glenview Capital Management
New York
|
+$13M |
| 4 |
RCMU
Rokos Capital Management (UK)
London,
United Kingdom
|
+$12.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.3M |
Top Sellers
| 1 |
MMA
Mizuho Markets Americas
New York
|
-$56.7M |
| 2 |
MMC
Mizuho Markets Cayman
Grand Cayman,
Cayman Islands
|
-$56.7M |
| 3 |
Morgan Stanley
New York
|
-$42.4M |
| 4 |
N
Natixis
Paris,
France
|
-$33.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$32.4M |
BHC Hedge Fund Activity: Q2 2023 in Review
232 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2023, worth a combined $2.13B — down 6.4% from $2.27B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of BHC and 37 opened new positions — a net loss of 1 holder — while 69 trimmed existing stakes and 59 added.
The largest buyer was Nomura Holdings, adding an estimated $44.2M. The largest seller was Mizuho Markets Americas, exiting entirely with an estimated $56.7M sold.
- 232 institutional investors held Bausch Health (BHC) as of Q2 2023, down from 235 in Q1 2023.
- Funds reported $2.13B of Bausch Health stock for Q2 2023, down 6.4% quarter-over-quarter.
- 37 funds opened new Bausch Health positions in Q2 2023 and 38 closed out, a net change of -1 holder.
- The largest Bausch Health buyer in Q2 2023 was Nomura Holdings, an estimated $44.2M added.
- The largest Bausch Health seller in Q2 2023 was Mizuho Markets Americas, an estimated $56.7M sold.
Based on aggregated 13F filings for Q2 2023.